Online inquiry

IVTScrip™ mRNA-Human ARHGAP29, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK23793MR)

This product GTTS-WK23793MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ARHGAP29 protein. This product can be used in MKI67+ progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001328664.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9411
UniProt ID Q52LW3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP29, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK23793MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK21981MR IVTScrip™ mRNA-Human ARHGAP10, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP10
GTTS-WK26769MR IVTScrip™ mRNA-Human ARFGAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARFGAP1
GTTS-WK24686MR IVTScrip™ mRNA-Human ARHGAP20, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP20
GTTS-WK23900MR IVTScrip™ mRNA-Human ASB8, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASB8
GTTS-WK8637MR IVTScrip™ mRNA-Human ADGRE2, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADGRE2
GTTS-WK17963MR IVTScrip™ mRNA-Human ANXA5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA5
GTTS-WK15232MR IVTScrip™ mRNA-Human ANKRD6, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD6
GTTS-WK21748MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →